C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, New York
Summary
The estimated net worth of Marshall Urist is at least $1.81 M dollars as of February 24, 2023. Marshall Urist is the EVP, Research & Investments of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $1.81 M.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.